SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-13-002333
Filing Date
2013-03-07
Accepted
2013-03-07 14:25:03
Documents
10
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a2212980z20-f.htm 20-F 5446532
2 EX-1.1 a2212980zex-1_1.htm EX-1.1 91068
3 EX-1.2 a2212980zex-1_2.htm EX-1.2 67149
4 EX-12.1 a2212980zex-12_1.htm EX-12.1 13186
5 EX-12.2 a2212980zex-12_2.htm EX-12.2 13333
6 EX-13.1 a2212980zex-13_1.htm EX-13.1 6218
7 EX-13.2 a2212980zex-13_2.htm EX-13.2 6342
8 EX-23.1 a2212980zex-23_1.htm EX-23.1 3034
9 EX-23.2 a2212980zex-23_2.htm EX-23.2 3005
10 EX-99.1 a2212980zex-99_1.htm EX-99.1 85802
  Complete submission text file 0001047469-13-002333.txt   5736800
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-31368 | Film No.: 13672898
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences